Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songnian Lin

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Diabetes|March 16, 2018
Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic ImpactsMary Courtney Moore, David E Kelley, Raul C Camacho, et al.
Molecular Pharmacology|September 23, 2011
Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogsJun-ichi Eiki, Yasufumi Nagata, Mayumi Futamura, et al.
JCI Insight|January 12, 2018
A glucose-responsive insulin therapy protects animals against hypoglycemiaRuojing Yang, Margaret Wu, Songnian Lin, et al.
Diabetes|May 15, 2008
Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in miceCarina P Tan, Yue Feng, Yun-Ping Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonistsChangyou Zhou, Cheng Tang, Eric Chang, et al.
Journal of Medicinal Chemistry|May 10, 2008
Design, synthesis, and biological evaluation of new-generation taxoidsIwao Ojima, Jin Chen, Liang Sun, et al.
Diabetes|November 4, 2017
Engineering Glucose Responsiveness Into InsulinNiels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Diabetes|March 1, 2018
Erratum. Engineering Glucose Responsiveness Into Insulin. Diabetes 2018;67:299-308Niels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Nature Communications|April 10, 2025
Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibitionMorgan E Walker, Wei Zhu, Janine H Peterson, et al.
Nature Communications|February 18, 2022
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonistsMargaret Wu, Ester Carballo-Jane, Haihong Zhou, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Diabetes|March 16, 2018
Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic ImpactsMary Courtney Moore, David E Kelley, Raul C Camacho, et al.
Molecular Pharmacology|September 23, 2011
Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogsJun-ichi Eiki, Yasufumi Nagata, Mayumi Futamura, et al.
JCI Insight|January 12, 2018
A glucose-responsive insulin therapy protects animals against hypoglycemiaRuojing Yang, Margaret Wu, Songnian Lin, et al.
Diabetes|May 15, 2008
Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in miceCarina P Tan, Yue Feng, Yun-Ping Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|January 13, 2010
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonistsChangyou Zhou, Cheng Tang, Eric Chang, et al.
Journal of Medicinal Chemistry|May 10, 2008
Design, synthesis, and biological evaluation of new-generation taxoidsIwao Ojima, Jin Chen, Liang Sun, et al.
Diabetes|November 4, 2017
Engineering Glucose Responsiveness Into InsulinNiels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Diabetes|March 1, 2018
Erratum. Engineering Glucose Responsiveness Into Insulin. Diabetes 2018;67:299-308Niels C Kaarsholm, Songnian Lin, Lin Yan, et al.
Nature Communications|April 10, 2025
Antibacterial macrocyclic peptides reveal a distinct mode of BamA inhibitionMorgan E Walker, Wei Zhu, Janine H Peterson, et al.
Nature Communications|February 18, 2022
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonistsMargaret Wu, Ester Carballo-Jane, Haihong Zhou, et al.
Pageof 4